Sanofi Pasteur
Part of Sanofi (Wikidata)
CompanyFrance
Sanofi Pasteur develops 2 assets, the furthest in phase 3 (FLU-v in influenza). Mostly vaccine acting on inflammation; based in France.
- 2
- Assets
- Furthest
- Phase 3
- 17
- Trials
- 0
- Signals
Pipeline
2Inactivated influenza virus vaccine inducing protective antibody responses
Phase 3, Vaccine, Inflammation, influenza, influenza immunization
Inactivated split-virion quadrivalent influenza vaccine inducing protective humoral immune responses against influenza strains.
Phase 3, Vaccine, influenza, influenza immunization
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials19
- Similar companies6
Updated 10 Oct 2026 · 50 sources